Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation
- PMID: 19786554
- PMCID: PMC5769454
- DOI: 10.4049/jimmunol.0900719
Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation
Abstract
IL-15 is a key component that regulates the development and homeostasis of NK cells and is delivered through a mechanism termed trans-presentation. During development, multiple events must proceed to generate a functional mature population of NK cells that are vital for tumor and viral immunity. Nevertheless, how IL-15 regulates these various events and more importantly what cells provide IL-15 to NK cells to drive these events is unclear. It is known dendritic cells (DC) can activate NK cells via IL-15 trans-presentation; however, the ability of DC to use IL-15 trans-presentation to promote the development and homeostatic maintenance of NK cell has not been established. In this current study, we show that IL-15 trans-presentation solely by CD11c(+) cells assists the in vivo development and maintenance of NK cells. More specifically, DC-mediated IL-15 trans-presentation drove the differentiation of NK cells, which included the up-regulation of the activating and inhibitory Ly49 receptors. Although these cells did not harbor a mature CD11b(high) phenotype, they were capable of degranulating and producing IFN-gamma upon stimulation similar to wild-type NK cells. In addition, DC facilitated the survival of mature NK cells via IL-15 trans-presentation in the periphery. Thus, an additional role for NK-DC interactions has been identified whereby DC support the developmental and homeostatic niche of NK cells.
Conflict of interest statement
The authors have no financial conflict of interest.
Figures
Similar articles
-
Different NK cell developmental events require different levels of IL-15 trans-presentation.J Immunol. 2011 Aug 1;187(3):1212-21. doi: 10.4049/jimmunol.1100331. Epub 2011 Jun 29. J Immunol. 2011. PMID: 21715685
-
Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.Oncotarget. 2015 Dec 29;6(42):44123-33. doi: 10.18632/oncotarget.6536. Oncotarget. 2015. PMID: 26675759 Free PMC article.
-
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.Int Immunol. 2009 May;21(5):599-606. doi: 10.1093/intimm/dxp029. Epub 2009 Mar 26. Int Immunol. 2009. PMID: 19325034
-
CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells.J Exp Med. 2007 Oct 29;204(11):2569-78. doi: 10.1084/jem.20071451. Epub 2007 Oct 8. J Exp Med. 2007. PMID: 17923507 Free PMC article.
-
Trans-presentation: a novel mechanism regulating IL-15 delivery and responses.Immunol Lett. 2010 Jan 4;127(2):85-92. doi: 10.1016/j.imlet.2009.09.009. Epub 2009 Oct 7. Immunol Lett. 2010. PMID: 19818367 Free PMC article. Review.
Cited by
-
M-CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation.EMBO Mol Med. 2023 Nov 8;15(11):e17694. doi: 10.15252/emmm.202317694. Epub 2023 Aug 28. EMBO Mol Med. 2023. PMID: 37635627 Free PMC article.
-
IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.J Immunol. 2015 Sep 1;195(5):2353-64. doi: 10.4049/jimmunol.1500300. Epub 2015 Jul 27. J Immunol. 2015. PMID: 26216888 Free PMC article.
-
IL-2 and Beyond in Cancer Immunotherapy.J Interferon Cytokine Res. 2018 Feb;38(2):45-68. doi: 10.1089/jir.2017.0101. J Interferon Cytokine Res. 2018. PMID: 29443657 Free PMC article. Review.
-
IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection.PLoS One. 2016 Feb 9;11(2):e0148452. doi: 10.1371/journal.pone.0148452. eCollection 2016. PLoS One. 2016. PMID: 26859674 Free PMC article.
-
NK cell development, homeostasis and function: parallels with CD8⁺ T cells.Nat Rev Immunol. 2011 Aug 26;11(10):645-57. doi: 10.1038/nri3044. Nat Rev Immunol. 2011. PMID: 21869816 Free PMC article. Review.
References
-
- Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 2007;7:329–339. - PubMed
-
- Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 2002;3:523–528. - PubMed
-
- Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP. Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J. Immunol. 2005;174:1213–1221. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials